Novartis’ Xolair scores European approval to treat chronic rhinosinusitis with nasal polyps
August 6, 2020Sales and Marketing Novartis, Xolair, rhinosinusitis
Novartis has snapped up approval from the European Commission for its anti-immunoglobulin E (IgE) antibody therapy Xolair (omalizumab) for the …
European Commission approves first drug for hepatitis D
August 6, 2020Business Services EC, hepatitis C, hepatitis D
The European Commission has approved Heplcudex (bulvirtide) as the first hepatitis D drug. It was jointly developed by researchers at …
US to pay Johnson and Johnson $1 billion for COVID-19 vaccine
August 6, 2020Business Services COVID-19, J&J, JJ, Johnson and Johnson, coronavirus
The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine. The …
US Democrats probe Trump administration’s $765 million loan to Kodak to produce drug ingredients
August 6, 2020Business Services
Democratic members of Congress are set to investigate the Trump administration’s $765 million federal loan awarded to Kodak as it …
Humanigen appoints Timothy Morris as Chief Operating Officer and Chief Financial Officer
August 5, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Humanigen have appointed Timothy E. Morris to its newly created role of Chief Operating Officer and Chief Financial Officer and …
NICE rejects mycosis fungoides-type cutaneous T-cell lymphoma therapy over data concerns
August 5, 2020Research and Development, Sales and Marketing Ledaga, NICE, lymphoma
NICE has announced its rejection of Ledaga (chlormethine gel), a topical therapy for the treatment of mycosis fungoides-type cutaneous T-cell …
NICE advises GPs to stop prescribing opioids for chronic pain
August 5, 2020Business Services, Research and Development COVID-19, coronavirus
The National Institutes of Health and Care Excellence has released its first guideline on the treatment of chronic pain and …
EMA expands label for UCB’s Cimzia in axial spondyloarthritis
August 5, 2020Research and Development, Sales and Marketing Cimzia, EMA, Europe
The European Medicines Agency has expanded the existing approval of UCB’s Cimzia (certolizumab pegol) to cover the treatment of axial …
Pharmafile.com’s weekly COVID-19 news round-up
August 5, 2020Research and Development COVID-19, Weekly round up, coronavirus
The coronavirus news this week is dominated by vaccine development, as the UK Government sealed another deal to procure an …
Researchers find Coca-Cola paid scientists to downplay how their drinks fuelled the obesity crisis
August 5, 2020Research and Development, Sales and Marketing Coca-Cola, Coke
Researchers have found that Coca-Cola paid an organization of scientists to downplay how the sugary drinks they sell fuelled the …
Medipharma appoints Former President of Janssen Chris Halyk to its Board of Directors
August 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Medipharma has appointed Chris Halyk, the former President of Janssen, to its Board of Directors. This is the third appointment …
VelosBio reveals new Chief Financial Officer
August 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing VelosBio, appointment
Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume …
Russia claims it will start mass immunisation with a COVID-19 vaccine from October
August 4, 2020Manufacturing and Production Russia, Vaccine, putin
The Russian government is claiming it will start production of a viable coronavirus vaccine candidate next month and begin the …
Sanofi indicted on manslaughter charges over its epilepsy drug Depakine
August 4, 2020Manufacturing and Production Sanofi, Vaccine
Sanofi is being investigated for manslaughter in France over the deaths of four babies whose mothers took its anti-epilepsy medication …
UK Government tells medicine suppliers to stockpile drugs for no-deal Brexit despite coronavirus concerns
August 4, 2020Manufacturing and Production UK, brexit, coronavirus
The British government has contacted medicine suppliers urging them to stockpile drugs for a possible no-deal Brexit, despite the pressure …
Novartis’ CAR T therapy Kymriah nails main goal in follicular lymphoma
August 4, 2020Manufacturing and Production, Research and Development CAR-T therapy, Cancer, Kymriah, Novartis, car t therapy
Novartis is celebrating the success of its one-time CAR T therapy Kymriah (tisagenlecleucel) in patients with relapsed or refractory (r/r) …
FDA expands approval for Janssen’s Spravato nasal spray to cover major depressive disorder with suicidal ideation
August 4, 2020Manufacturing and Production FDA Janssen, Spravato, depression
The FDA has moved to expand the existing approval of Janssen’s Spravato (esketamine) CIII nasal spray to include treatment of symptoms …
CAR T cell therapy is revolutionising cancer treatment, but at what cost?
August 3, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature
CAR T cell therapy is one of the latest innovations in gene therapy. The process is primarily used to treat …
Novartis’ Cosentyx gets European go-ahead in paediatric plaque psoriasis
August 3, 2020Sales and Marketing Cosentyx, Europe, Novartis, pharma, psoriasis
Novartis’ interleukin-17A (IL-17A) inhibitor Cosentyx (secukinumab) has chalked up approval from the European Commission (EC) for the treatment of patients …
EU agrees deal with Sanofi for COVID-19 vaccine supply
August 3, 2020Sales and Marketing COVID, COVID-19, coronavirus
The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
